GRAIL, Inc. (GRAL) Competitors & Peers
The 5 largest companies in the same industry as GRAIL, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| TMO | Peer | $657.77 | P/E 32.9RSI 56Cap 226.5 B |
| DHR | Peer | $214.22 | P/E 37.9RSI 57Cap 149.0 B |
| NTRA | Peer | $362.70 | RSI 71Cap 52.3 B |
| IQV | Peer | $269.19 | P/E 33.6RSI 67Cap 44.5 B |
| A | Peer | $156.47 | P/E 28.6RSI 44Cap 40.8 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- ILMNPartner
Grail was spun off from Illumina and utilizes Illumina next-generation sequencing systems for its Galleri tests.
Model-inferred, unverified — treat as a lead, not evidence - GHCompetitor
Competes in liquid biopsy oncology screening and multi-cancer detection bids.
Model-inferred, unverified — treat as a lead, not evidence